Ingevity Corp (NGVT) financial statements: income statement, balance sheet and cash flow
Ingevity Corp's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Ingevity Corp reported revenue of $1.2B (-17.0% year on year) and net income of ($167.1M) (+61.2% year on year).
Income statement
Ingevity Corp income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net sales
$1.2B
$1.4B
$1.7B
$1.7B
Cost of sales
$706.1M
$951.7M
$1.2B
$1.1B
Gross profit
$461.5M
$454.7M
$471.9M
$570.1M
Selling, general, and administrative expenses
$171.2M
$166.7M
$183.7M
$198.8M
Research and technical expenses
$28.4M
$28.1M
$31.8M
$30.3M
Restructuring and other (income) charges, net
$12.8M
$186.2M
$170.2M
$13.8M
Goodwill impairment charge
$183.8M
$349.1M
—
—
Long lived asset impairment charge
$109.3M
—
—
—
Acquisition-related costs
$0
$300.0K
$3.6M
$5.0M
Other (income) expense, net
$25.0M
$169.8M
$5.7M
($1.7M)
Interest expense
$78.3M
$97.8M
$93.3M
$61.8M
Interest income
($5.2M)
($7.7M)
($6.3M)
($7.5M)
Income (loss) from continuing operations before income taxes
($142.1M)
($535.6M)
($10.1M)
$269.6M
Provision (benefit) for income taxes on continuing operations
$8.2M
($105.3M)
($4.7M)
$58.0M
Net income (loss) from continuing operations
($150.3M)
—
—
—
Income (loss) from discontinued operations, net of income taxes
($16.8M)
—
—
—
Net income (loss)
($167.1M)
($430.3M)
($5.4M)
$211.6M
Basic earnings (loss) per share from continuing operations (usd per share)
-$4.15
—
—
—
Basic earnings (loss) per share from continuing operations (usd per share)
-$0.46
—
—
—
Basic earnings (loss) per share (usd per share)
-$4.61
-$11.85
-$0.15
$5.54
Diluted earnings (loss) per share from continuing operations (usd per share)
-$4.15
—
—
—
Diluted earnings (loss) per share from discontinued operations (usd per share)
-$0.46
—
—
—
Diluted earnings (loss) per share (usd per share)
-$4.61
-$11.85
-$0.15
$5.50
Ingevity Corp income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Net sales
$314.1M
$258.0M
$333.1M
$365.1M
Cost of sales
$175.1M
$141.6M
$199.2M
$227.2M
Gross profit
$139.0M
$116.4M
$133.9M
$137.9M
Selling, general, and administrative expenses
$39.0M
$40.7M
$44.1M
$44.2M
Research and technical expenses
$6.1M
$6.7M
$7.0M
$7.8M
Restructuring and other (income) charges, net
$1.7M
$500.0K
$1.0M
$21.9M
Goodwill impairment charge
$0
—
$0
$183.8M
Long-lived asset impairment charge
$32.1M
—
—
—
Other (income) expense, net
($4.8M)
$22.4M
$1.2M
$4.3M
Interest expense, net
$14.2M
$15.9M
$18.4M
$18.6M
Income (loss) from continuing operations before income taxes
$50.7M
$30.2M
$62.2M
($142.7M)
(Provision) benefit for income taxes on continuing operations
$10.9M
$6.8M
$21.4M
$3.8M
Net income (loss) from continuing operations
$39.8M
$23.4M
$40.8M
—
Income (loss) from discontinued operations, net of income taxes
($4.5M)
$36.4M
$2.7M
—
Net income (loss)
$35.3M
$59.8M
$43.5M
($146.5M)
Basic earnings (loss) per share from continuing operations (usd per share)
$1.15
$0.66
$1.12
—
Basic earnings (loss) per share from discontinued operations (usd per share)
-$0.13
$1.04
$0.08
—
Basic earnings (loss) per share (usd per share)
$1.02
$1.70
$1.20
-$4.02
Diluted earnings (loss) per share from continuing operations (usd per share)
$1.13
$0.65
$1.10
—
Diluted earnings (loss) per share from discontinued operations (usd per share)
-$0.13
$1.01
$0.08
—
Diluted earnings (loss) per share (usd per share)
$1.00
$1.66
$1.18
-$4.02
Balance sheet
Ingevity Corp balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and cash equivalents
$78.1M
$68.0M
$95.9M
$76.7M
Accounts receivable, net of allowance of $1.5 - 2025 and $0.6 - 2024
$127.2M
$141.0M
$182.0M
$224.8M
Inventories, net
$186.0M
$226.8M
$308.8M
$335.0M
Prepaid and other current assets
$47.0M
$57.4M
$71.9M
$42.5M
Current assets of discontinued operations
$15.9M
—
—
—
Current assets
$454.2M
$493.2M
$658.6M
$679.0M
Property, plant, and equipment, net
$608.1M
$658.9M
$762.2M
$798.6M
Operating lease assets, net
$29.5M
$50.4M
$67.1M
$56.6M
Goodwill
$4.3M
$175.2M
$527.5M
$518.5M
Other intangibles, net
$176.1M
$278.8M
$336.1M
$404.8M
Deferred income taxes
$117.0M
$117.9M
$11.6M
$5.7M
Restricted investment, net of allowance of $0.2 - 2025 and $0.2 - 2024
$84.4M
$81.6M
$79.1M
$78.0M
Strategic investments
$83.1M
$87.3M
$99.2M
$109.8M
Other assets
$74.9M
$79.3M
$81.9M
$85.5M
Noncurrent assets of discontinued operations
$19.5M
—
—
—
Total Assets
$1.7B
$2.0B
$2.6B
$2.7B
Accounts payable
$92.0M
$94.5M
$158.4M
$174.8M
Accrued expenses
$148.0M
$58.1M
$72.3M
$54.4M
Accrued payroll and employee benefits
$34.6M
$27.7M
$19.9M
$53.3M
Current operating lease liabilities
$11.8M
$16.9M
$18.7M
$16.5M
Notes payable and current maturities of long-term debt
$47.1M
$61.3M
$84.4M
$900.0K
Income taxes payable
$4.7M
$5.6M
$9.2M
$3.6M
Current liabilities of discontinued operations
$3.1M
—
—
—
Current liabilities
$341.3M
$264.1M
$362.9M
$303.5M
Long-term debt including finance lease obligations
$1.2B
$1.3B
$1.4B
$1.5B
Noncurrent operating lease liabilities
$22.4M
$36.8M
$48.6M
$40.8M
Deferred income taxes
$55.1M
$56.2M
$70.9M
$106.5M
Other liabilities
$40.5M
$130.6M
$126.7M
$114.9M
Noncurrent liabilities of discontinued operations
$700.0K
—
—
—
Total Liabilities
$1.6B
$1.8B
$2.0B
$2.0B
Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2025 and 2024)
$0.00
$0.00
$0.00
$0.00
Common stock (par value $0.01 per share; 300,000,000 shares authorized; 43,891,710 and 43,630,211 issued and 35,485,876 and 36,350,425 outstanding at 2025 and 2024, respectively)
$400000.00
$400000.00
$400000.00
$400000.00
Additional paid-in capital
$195.7M
$176.8M
$164.9M
$153.0M
Retained earnings
$404.9M
$572.0M
$1.0B
$1.0B
Accumulated other comprehensive income (loss)
$500.0K
($41.4M)
($26.7M)
($46.8M)
Treasury stock, common stock, at cost (8,405,834 shares - 2025 and 7,279,786 shares - 2024)
-571.8M
-512.6M
-509.5M
-416.0M
Total Equity
$29.7M
$195.2M
$631.4M
$698.3M
Total Liabilities and Equity
$1.7B
$2.0B
$2.6B
$2.7B
Ingevity Corp balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and cash equivalents
$97.4M
$95.4M
$83.4M
$76.9M
Accounts receivable, net of allowance of $1.1 and $1.5
$155.8M
$151.2M
$168.1M
$193.4M
Inventories, net
$154.0M
$203.6M
$193.7M
$220.3M
Restricted investment, net of allowance of zero
$85.8M
$85.1M
—
—
Prepaid and other current assets
$50.8M
$46.5M
$45.8M
$45.4M
Current assets of discontinued operations
$0
$0
$31.2M
—
Current assets
$543.8M
$581.8M
$522.2M
$536.0M
Property, plant, and equipment, net
$575.0M
$599.8M
$629.7M
$654.6M
Operating lease assets, net
$33.0M
$36.6M
$26.6M
$39.4M
Goodwill
$4.3M
$4.3M
$4.3M
$4.3M
Other intangibles, net
$137.3M
$168.0M
$267.6M
$279.1M
Deferred income taxes
$87.0M
$100.7M
$93.2M
$118.5M
Restricted investment, net of allowance of $0.2
$0
$0
—
—
Strategic investments
$83.4M
$82.9M
$105.2M
$85.3M
Other assets
$73.7M
$76.1M
$77.0M
$77.5M
Noncurrent assets of discontinued operations
$0
$0
$24.3M
—
Total Assets
$1.5B
$1.7B
$1.8B
$1.9B
Accounts payable
$88.0M
$85.0M
$100.9M
$101.5M
Accrued expenses
$60.3M
$165.0M
$159.1M
$150.8M
Accrued payroll and employee benefits
$24.9M
$20.3M
$28.6M
$25.5M
Current operating lease liabilities
$12.2M
$13.3M
$10.1M
$14.8M
Notes payable and current maturities of long-term debt
$144.0M
$121.9M
$102.0M
$94.7M
Income taxes payable
$8.2M
$3.9M
$6.3M
$5.8M
Current liabilities of discontinued operations
$0
$0
$4.6M
—
Current liabilities
$337.6M
$409.4M
$411.6M
$393.1M
Long-term debt including finance lease obligations
$1.1B
$1.1B
$1.2B
$1.2B
Noncurrent operating lease liabilities
$23.9M
$27.1M
$20.9M
$30.4M
Deferred income taxes
$44.2M
$53.3M
$56.2M
$57.1M
Other liabilities
$28.7M
$39.1M
$41.7M
$40.8M
Noncurrent liabilities of discontinued operations
$0
$0
$6.8M
—
Total Liabilities
$1.5B
$1.6B
$1.7B
$1.8B
Preferred stock (par value $0.01 per share; 50,000,000 shares authorized; zero issued and outstanding at 2026 and 2025)
$0.00
$0.00
$0.00
$0.00
Common stock (par value $0.01 per share; 300,000,000 shares authorized; 44,217,477 and 43,891,710 issued and 34,483,413 and 35,485,876 outstanding at 2026 and 2025, respectively)
$400000.00
$400000.00
$400000.00
$400000.00
Additional paid-in capital
$209.1M
$203.4M
$191.2M
$185.3M
Retained earnings
$500.0M
$464.7M
$489.5M
$446.0M
Accumulated other comprehensive income (loss)
$1.0M
($1.6M)
($2.4M)
$4.2M
Treasury stock, common stock, at cost (9,734,064 shares - 2026 and 8,405,834 shares - 2025)
-663.6M
-628.0M
-540.6M
-515.2M
Total Equity
$46.9M
$38.9M
$138.1M
$120.7M
Total Liabilities and Equity
$1.5B
$1.7B
$1.8B
$1.9B
Cash flow statement
Ingevity Corp cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income (loss)
($167.1M)
($430.3M)
($5.4M)
$211.6M
Depreciation and amortization
$106.4M
$108.3M
$122.8M
$108.8M
Non cash operating lease costs
$14.7M
$19.1M
$18.6M
$16.1M
Deferred income taxes
($4.7M)
($121.4M)
($44.7M)
($5.0M)
Disposal/impairment of assets
$3.2M
$1.3M
$4.3M
$2.5M
Restructuring and other (income) charges, net
$55.7M
$186.2M
$170.2M
$0
CTO resales
$0
$52.7M
—
—
LIFO liquidation
($6.8M)
($18.7M)
$72.9M
$10.0M
Share-based compensation
$18.3M
$11.9M
$10.6M
$16.1M
(Gain) loss on strategic investment
$26.2M
$11.4M
—
—
Pension and other postretirement benefit costs
$1.2M
$1.5M
$1.6M
$1.4M
Goodwill impairment charge
$183.8M
$349.1M
—
—
Impairment, long-lived asset, held-for-use
$109.3M
—
—
—
Other non-cash items
$7.6M
$17.0M
$36.2M
$18.4M
Accounts receivable, net
$12.2M
$38.2M
$42.7M
($42.1M)
Inventories, net
$40.2M
$86.2M
($75.6M)
($63.7M)
Prepaid and other current assets
$1.3M
$7.7M
($6.6M)
($800.0K)
Planned major maintenance outage
($6.5M)
($6.5M)
($12.8M)
($9.1M)
Accounts payable
($2.6M)
($63.4M)
($14.6M)
$42.7M
Accrued expenses
($14.1M)
($1.0M)
($7.7M)
$800.0K
Accrued payroll and employee benefits
$6.9M
$8.0M
($33.5M)
$5.4M
Income taxes
($1.2M)
($13.8M)
$6.4M
$4.9M
Operating leases
($19.5M)
($21.7M)
($22.5M)
($18.8M)
Restructuring and other spending
($46.1M)
($59.3M)
($44.0M)
—
CTO resales
$6.2M
($46.1M)
($10.6M)
—
Changes in all other operating assets and liabilities, net
$6.6M
$12.2M
$15.1M
$13.9M
Net cash provided by (used in) operating activities
$331.2M
$128.6M
$205.1M
$313.1M
Capital expenditures
($57.7M)
($77.6M)
($109.8M)
($142.5M)
Proceeds from disposition of assets
$3.6M
—
—
—
Sale (purchase) of strategic investments, net
($16.4M)
—
—
—
Restricted investment
$13.0M
—
—
—
Other investing activities, net
$0
($1.6M)
$3.4M
($4.2M)
Net cash provided by (used in) investing activities
($57.5M)
($79.5M)
($77.3M)
($553.9M)
Proceeds from revolving credit facility and other borrowings
$291.3M
$404.5M
$376.3M
—
Payments on revolving credit facility and other borrowings
($483.6M)
($470.6M)
($382.9M)
($336.7M)
Debt issuance costs
$0
$0
($400.0K)
($3.0M)
Financing lease obligations, net
($1.3M)
($1.0M)
($700.0K)
($900.0K)
Tax payments related to withholdings on vested equity awards
($3.7M)
($3.1M)
($4.8M)
($2.2M)
Proceeds and withholdings from share-based compensation plans, net
$1.4M
$0
$4.7M
$4.1M
Repurchases of common stock under publicly announced plan
($56.3M)
$0
($92.1M)
($145.2M)
Net cash provided by (used in) financing activities
($252.2M)
($70.2M)
($99.9M)
$48.1M
Increase (decrease) in cash, cash equivalents, and restricted cash
$21.5M
($21.1M)
$27.9M
($192.7M)
Effect of exchange rate changes on cash
$4.5M
($4.2M)
($300.0K)
($6.0M)
Change in cash, cash equivalents, and restricted cash
$26.0M
($25.3M)
$27.6M
($198.7M)
Cash, cash equivalents, and restricted cash at beginning of period
$86.6M
$111.9M
$84.3M
$276.0M
Ingevity Corp cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net income (loss)
$95.1M
$59.8M
($82.5M)
($126.0M)
Depreciation and amortization
$44.7M
$22.7M
$78.5M
$50.5M
Non-cash operating lease costs
$5.4M
$2.8M
$11.5M
$8.3M
Deferred income taxes
$20.1M
$15.5M
$20.9M
($5.1M)
Restructuring and other (income) charges, net
$14.9M
$8.3M
$44.1M
$34.2M
LIFO charge (liquidation)
$800.0K
$600.0K
($8.5M)
($6.5M)
Share-based compensation
$9.0M
$4.8M
$13.8M
$8.5M
Impairment of license agreement
$2.8M
$2.8M
—
—
(Gain) loss on sale of business
($62.8M)
($55.6M)
—
—
(Gain) loss on strategic investment
$0
—
$2.5M
$2.5M
Goodwill impairment charge
$0
—
$183.8M
$183.8M
Long-lived asset impairment charge
$32.1M
—
—
—
Litigation charges
$16.2M
$16.2M
—
—
Other non-cash items
$6.5M
$2.6M
$7.5M
$5.9M
Accounts receivable, net
($41.0M)
($24.2M)
($33.9M)
($49.1M)
Inventories, net
($15.4M)
($24.5M)
$24.2M
$17.8M
Prepaid and other current assets
($13.2M)
($2.2M)
($600.0K)
($2.0M)
Planned major maintenance outage
($3.3M)
—
—
$3.0M
Accounts payable
($700.0K)
($11.6M)
$5.9M
$6.1M
Accrued expenses
$12.8M
$4.4M
$1.0M
($8.2M)
Accrued payroll and employee benefits
($9.9M)
($14.2M)
$1.0M
($2.5M)
Income taxes
$11.6M
$1.3M
$1.3M
$9.7M
Restructuring and other cash outflow, net
($15.4M)
($8.6M)
($35.4M)
($23.1M)
Operating leases
($8.0M)
($4.1M)
($15.0M)
($10.5M)
CTO resales cash inflow, net
$0
$0
$6.2M
$6.2M
Litigation settlement payment
($113.2M)
—
—
—
Changes in other operating assets and liabilities, net
($4.9M)
$1.2M
$6.0M
$6.9M
Net cash provided by (used in) operating activities
($15.8M)
($2.0M)
$234.1M
$104.4M
Capital expenditures
($20.6M)
($10.3M)
($34.1M)
($22.2M)
Proceeds from sale of businesses
$156.3M
$93.1M
—
—
Proceeds from Restricted investment
$47.8M
$24.7M
—
—
Proceeds from disposition of assets
$0
$0
—
$3.6M
Other investing activities, net
($1.8M)
($1.2M)
$12.7M
$4.3M
Net cash provided by (used in) investing activities
$181.7M
$106.3M
($42.4M)
($14.3M)
Proceeds from revolving credit facility and other borrowings
$877.5M
$713.8M
$209.5M
$158.5M
Payments on revolving credit facility and other borrowings
($885.6M)
($718.0M)
($350.0M)
($229.3M)
Debt issuance costs
($4.0M)
($4.0M)
—
—
Finance lease obligations, net
($600.0K)
($300.0K)
($900.0K)
($600.0K)
Tax payments related to withholdings on vested equity awards
($5.7M)
($4.3M)
($2.8M)
($2.6M)
Proceeds and withholdings from share-based compensation plans, net
$5.8M
$3.3M
$600.0K
—
Repurchases of common stock under stock repurchase plan
($86.8M)
($52.3M)
($25.2M)
—
Net cash provided by (used in) financing activities
($99.4M)
($61.8M)
($168.8M)
($74.0M)
Increase (decrease) in cash, cash equivalents, and restricted cash
$66.5M
$42.5M
$22.9M
$16.1M
Effect of exchange rate changes on cash
$1.8M
$200.0K
$4.9M
$4.4M
Change in cash, cash equivalents, and restricted cash